Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Incannex Healthcare (IXHL) over the last 3 years, with Q3 2025 value amounting to $57.9 million.

  • Incannex Healthcare's Net Cash Flow rose 262220.29% to $57.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 million, marking a year-over-year increase of 65518.52%. This contributed to the annual value of $8.9 million for FY2025, which is 15504.9% up from last year.
  • Latest data reveals that Incannex Healthcare reported Net Cash Flow of $57.9 million as of Q3 2025, which was up 262220.29% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Incannex Healthcare's Net Cash Flow registered a high of $57.9 million during Q3 2025, and its lowest value of -$6.0 million during Q3 2023.
  • For the 3-year period, Incannex Healthcare's Net Cash Flow averaged around $5.6 million, with its median value being -$2.2 million (2023).
  • In the last 5 years, Incannex Healthcare's Net Cash Flow skyrocketed by 2946.35% in 2024 and then soared by 262220.29% in 2025.
  • Quarter analysis of 3 years shows Incannex Healthcare's Net Cash Flow stood at -$2.2 million in 2023, then grew by 29.46% to -$1.5 million in 2024, then soared by 3899.02% to $57.9 million in 2025.
  • Its Net Cash Flow was $57.9 million in Q3 2025, compared to $8.1 million in Q2 2025 and $4.6 million in Q1 2025.